A 3-year population study of 3,723 people with anxiety disorders found that while cannabis users had lower remission rates in raw numbers, these differences disappeared after adjusting for baseline factors, suggesting pre-existing characteristics rather than cannabis use explain poorer outcomes.
Read this if you have an anxiety disorder and use cannabis, or if you are interested in whether cannabis affects anxiety outcomes.
Cannabis-anxiety association disappeared after adjusting for baseline factors
What the researchers found
Researchers analyzed data from 3,723 individuals with diagnosed anxiety disorders (social anxiety, panic disorder, generalized anxiety disorder, specific phobias) from the National Epidemiologic Survey on Alcohol and Related Conditions.
In unadjusted analysis, remission rates from anxiety disorders decreased with increasing levels of cannabis use, suggesting cannabis worsened outcomes.
However, after adjusting for baseline confounders, the association between cannabis use and lower remission rates was no longer statistically significant. This means that pre-existing differences between cannabis users and non-users, not cannabis itself, likely explained the poorer outcomes.
Two specific exceptions emerged: individuals with cannabis use disorders were significantly more likely to report breaking up from a romantic relationship (OR 3.85) and repeatedly quitting school (OR 6.02) compared to non-users, even after adjustment.
Why it matters
This finding challenges the assumption that cannabis use worsens anxiety disorders. The disappearance of the association after controlling for baseline factors suggests that people who use cannabis already differ from non-users in ways that predict worse outcomes, independent of their cannabis use.
The numbers in context
3,723 individuals with anxiety disorders. Unadjusted: lower remission with more cannabis use. Adjusted: no significant difference in remission. Cannabis use disorder linked to relationship breakup (OR 3.85) and quitting school (OR 6.02).
How the study worked
Longitudinal analysis of Waves 1 and 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Focused on 3,723 individuals with any anxiety disorder at Wave 1. Cannabis users and those with cannabis use disorders compared to non-users on remission, functioning, and quality of life at Wave 2 (approximately 3 years later), controlling for baseline confounders.
What this study cannot tell us
Observational design cannot fully rule out residual confounding even after adjustment. Self-reported cannabis use and diagnostic assessments are subject to bias. The 3-year follow-up may be too short to detect longer-term effects. Cannabis use patterns (frequency, potency, cannabinoid profile) were not detailed.
How to read the evidence
Large population-based longitudinal study (NESARC) with baseline confounder adjustment provides moderate evidence, though observational design limits causal inference.
When this study was published
Published in 2018 using NESARC data. Cannabis potency and use patterns have changed since the original survey.
The bigger picture
This adds to a growing body of research suggesting that many observed associations between cannabis use and psychiatric outcomes may reflect shared vulnerabilities rather than direct cannabis effects. The methodology of adjusting for baseline confounders is critical for interpreting observational studies on cannabis and mental health.
Questions still open
- What specific baseline factors account for the apparent cannabis-anxiety association? Would longer follow-up reveal effects not captured in 3 years? Does the type of anxiety disorder matter for cannabis effects on outcomes?
Common questions
Does cannabis make anxiety disorders worse?
Were there any negative effects found?
Read the original research
Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study.
Depression and anxiety, 35(6), 490-501
Citation
Feingold, Daniel; Rehm, Jürgen; Factor, Hagai; Redler, Avigayil; Lev-Ran, Shaul. (2018). Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study.. Depression and anxiety, 35(6), 490-501. https://doi.org/10.1002/da.22735
Explore the wider topic
- Weed Withdrawal Anxiety in Public: When Leaving the House Feels Impossible
- The DARE Response to Anxiety for Cannabis Withdrawal
- The Cannabis Withdrawal Anxiety Toolkit: Quick Techniques That Work
- Why Anxiety Gets Worse Before It Gets Better After Quitting Weed
- Breathing Exercises for Weed Withdrawal Anxiety
- Cannabis-Induced Anxiety: When Weed Stops Being Fun
- Does Weed Help or Hurt Anxiety? What Research Actually Shows
- Grounding Techniques for Cannabis Withdrawal: A Practical Toolkit
- Quitting Weed with Health Anxiety: Why Every Symptom Feels Like a Crisis
- How to Manage Anxiety Without Weed: 15 Evidence-Based Alternatives
- Quitting Weed with Anxiety Disorder: A Careful Approach
- Quitting Weed When You're on Anxiety Medication: What to Know
- Self-Medicating Anxiety with Weed: Why It Works Until It Doesn't
- Do I Need Therapy to Quit Weed? When Professional Help Makes Sense
- Weed and Anxiety: The Paradox That Traps People
- The Biphasic Effect: Low-Dose Calms, High-Dose Panics
- Weed and Generalized Anxiety Disorder (GAD): Why It Backfires
- Weed and Panic Attacks: The Connection Nobody Talks About
- Weed and Paranoia: When Cannabis Turns Your Mind Against You
- Weed and Social Anxiety: Why It Feels Like the Only Thing That Helps
- Why Weed Stopped Working for Your Anxiety
- Weed Withdrawal Anxiety: Understanding the Panic and How to Cope
- Weed Withdrawal Panic Attacks at Night: Why They Happen and How to Get Through Them
- Going Back to Work During Weed Withdrawal: Managing Anxiety and Staying Functional
- Withdrawal Anxiety vs Pre-Existing Anxiety: How to Tell the Difference